215 related articles for article (PubMed ID: 18799868)
1. Centrilobular fibrosis: an underrecognized pattern in systemic sclerosis.
de Souza RB; Borges CT; Capelozzi VL; Parra ER; Jatene FB; Kavakama J; Kairalla RA; Bonfá E
Respiration; 2009; 77(4):389-97. PubMed ID: 18799868
[TBL] [Abstract][Full Text] [Related]
2. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence.
Christmann RB; Wells AU; Capelozzi VL; Silver RM
Semin Arthritis Rheum; 2010 Dec; 40(3):241-9. PubMed ID: 20494406
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary manifestations of Sjögren's syndrome.
Shi JH; Liu HR; Xu WB; Feng RE; Zhang ZH; Tian XL; Zhu YJ
Respiration; 2009; 78(4):377-86. PubMed ID: 19390161
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
5. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
[TBL] [Abstract][Full Text] [Related]
6. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
7. Systemic sclerosis and interstitial lung disease: a pilot study using pulse intravenous methylprednisolone and cyclophosphamide to assess the effect on high resolution computed tomography scan and lung function.
Griffiths B; Miles S; Moss H; Robertson R; Veale D; Emery P
J Rheumatol; 2002 Nov; 29(11):2371-8. PubMed ID: 12415594
[TBL] [Abstract][Full Text] [Related]
8. Effect of Bosentan on systemic sclerosis-associated interstitial lung disease ineligible for cyclophosphamide therapy: a prospective open-label study.
Furuya Y; Kuwana M
J Rheumatol; 2011 Oct; 38(10):2186-92. PubMed ID: 21885489
[TBL] [Abstract][Full Text] [Related]
9. Centrilobular fibrosis: a novel histological pattern of idiopathic interstitial pneumonia.
de Carvalho ME; Kairalla RA; Capelozzi VL; Deheinzelin D; do Nascimento Saldiva PH; de Carvalho CR
Pathol Res Pract; 2002; 198(9):577-83. PubMed ID: 12440779
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.
Volpinari S; La Corte R; Bighi S; Ravenna F; Prandini N; Lo Monaco A; Trotta F
Rheumatol Int; 2011 Sep; 31(9):1183-8. PubMed ID: 20352228
[TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
[TBL] [Abstract][Full Text] [Related]
12. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Desai SR; Veeraraghavan S; Hansell DM; Nikolakopolou A; Goh NS; Nicholson AG; Colby TV; Denton CP; Black CM; du Bois RM; Wells AU
Radiology; 2004 Aug; 232(2):560-7. PubMed ID: 15286324
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease.
Pakas I; Ioannidis JP; Malagari K; Skopouli FN; Moutsopoulos HM; Vlachoyiannopoulos PG
J Rheumatol; 2002 Feb; 29(2):298-304. PubMed ID: 11842824
[TBL] [Abstract][Full Text] [Related]
14. A long-term prospective randomized controlled study of non-specific interstitial pneumonia (NSIP) treatment in scleroderma.
Domiciano DS; Bonfá E; Borges CT; Kairalla RA; Capelozzi VL; Parra E; Christmann RB
Clin Rheumatol; 2011 Feb; 30(2):223-9. PubMed ID: 20544245
[TBL] [Abstract][Full Text] [Related]
15. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis.
Swartz JS; Chatterjee S; Parambil JG
J Clin Rheumatol; 2010 Sep; 16(6):284-6. PubMed ID: 20808169
[TBL] [Abstract][Full Text] [Related]
16. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
[TBL] [Abstract][Full Text] [Related]
17. Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase.
Airò P; Danieli E; Rossi M; Frassi M; Cavazzana I; Scarsi M; Grottolo A; Franceschini F; Zambruni A
Clin Exp Rheumatol; 2007; 25(2):293-6. PubMed ID: 17543156
[TBL] [Abstract][Full Text] [Related]
18. Determinants of pulmonary function improvement in patients with scleroderma and interstitial lung disease.
Tzelepis GE; Plastiras SC; Karadimitrakis SP; Vlachoyiannopoulos PG
Clin Exp Rheumatol; 2007; 25(5):734-9. PubMed ID: 18078622
[TBL] [Abstract][Full Text] [Related]
19. [Interstitial lung disease in systemic sclerosis].
Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D
Presse Med; 2006 Dec; 35(12 Pt 2):1943-51. PubMed ID: 17159721
[TBL] [Abstract][Full Text] [Related]
20. [Interstitial lung disease in systemic sclerosis].
Mouthon L; Berezné A; Brauner M; Kambouchner M; Guillevin L; Valeyre D
Rev Mal Respir; 2007 Oct; 24(8):1035-46. PubMed ID: 18033190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]